SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-177034
Filing Date
2022-06-21
Accepted
2022-06-21 07:06:03
Documents
12
Period of Report
2022-06-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d353681d8k.htm   iXBRL 8-K 45375
  Complete submission text file 0001193125-22-177034.txt   167874

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA krtx-20220615.xsd EX-101.SCH 2848
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE krtx-20220615_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krtx-20220615_pre.xml EX-101.PRE 11256
6 EXTRACTED XBRL INSTANCE DOCUMENT d353681d8k_htm.xml XML 3337
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38958 | Film No.: 221026013
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences